Engine Biosciences logo

Engine Biosciences

Deciphering Biological Complexity to Unleash Many Impactful Medicines

36 employees · est. 2014 · Singapore, Singapore

VS
Fluicell logo

Fluicell

Making tissue therapeutics possible to defeat serious disease

16 employees · est. 2012 · Sweden

Fluicell is the older company (2014 vs 2012).

Side-by-Side Comparison

Engine Biosciences Fluicell
Founded
2014 2012 older
Headquarters
Singapore, Singapore Sweden
Employees
36 16
Industry
AI, Biotechnology, Health Care Biotechnology, Health Care, Pharmaceutical
Funding Stage
Series A Post Ipo Equity
Total Funding
$103.00M $4.00M
Funding Rounds
5 2
Services
development of new cancer medicines, biotechnological research, pharmaceutical advancements Not tracked yet
Target Customers
pharmaceutical companies, healthcare providers, research institutions, oncologists Not tracked yet
Taxonomy
Network Biomedicine, Drug Discovery, Cellular Reprogramming, High-throughput Experimentation, Genomics, R&D Acceleration, Biological Networks, Patented Technology, Venture-backed, Partnerships, Disease Indications, Platform Development Regenerative Medicine, Drug Screening, Tissue Therapeutics, Bioprinting, Microfluidics, Biomedicine, Single-Cell Biology, Single-Cell Pharmacology, Cell Therapy, Diabetes, Precision Engineering, Transplantable Tissues, Patent-Protected R&D
Website
enginebio.com fluicell.com
Engine Biosciences logo

About Engine Biosciences

Engine Biosciences, founded in 2014, stands at the intersection of biotechnology and artificial intelligence, revolutionizing the drug discovery landscape. Headquartered in Singapore and maintaining significant operations in San Francisco and Asia, this innovative tech company specializes in network...

Fluicell logo

About Fluicell

Fluicell is a Swedish biotechnology startup dedicated to revolutionizing disease treatment through innovative tissue solutions for regenerative medicine and drug screening. The company's groundbreaking Nexocyte platform, developed over two decades of disruptive R&D, introduces novel approaches to co...

We will tell you when either one moves

BounceWatch watches Engine Biosciences and Fluicell for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Engine Biosciences and Fluicell — by email.

Frequently Asked Questions

Engine Biosciences — Deciphering Biological Complexity to Unleash Many Impactful Medicines. Fluicell — Making tissue therapeutics possible to defeat serious disease . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Engine Biosciences has raised $103.00M while Fluicell has raised $4.00M.
Engine Biosciences and Fluicell operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Engine Biosciences with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Engine Biosciences on 15 Jun 2026, and Fluicell on 14 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy